Fantastic overview on how to image the tricuspid valve - extremely useful for interventional cardiologists as well! @chrismeduri @GilbertTangMD @nickaram #TreatTR

Congratulations @bogdan_popescu1 for the excellent VHD Forum celebrated in Bucharest 👐handson session on transthoracic and trans esophageal echo 🩻data acquisition with the new Pioneer US system @GEHealthCare @GE_IanMc 🏩discussions on the new @escardio VHD guidelines

I have translated into slides the topics and references used by the 2025 Guidelines Task Force on valvular heart disease to justify the recommendation for TAVI in patients aged 70 years or older. Their key argument is a certain degree of pragmatism — they consider age as a

Are you around 10-11 october in Bucharest? are you passionate about #valvular heart disease?Come to the 3rd edition of the Valvular Heart Disease Forum 📝register 👉 https://t.co/5rPNIrijf7 🗳️participate in lively discussions 👨‍🏫learn the new @escardio guidelines @EACVIPresident

Please join us. @MontefioreNYC @WPHospital @EinsteinMed

Join us for the Cath Conference with @FabienPraz! 🎙️Topic of Discussion: 2025 ESC/EACTS Guidelines for Valvular Heart Disease 📆 7.30 AM (EST) - Tuesday, September 16, 2025 🔗 https://t.co/rIfNrxHWvm @azeemlatib @AndreaScotti21 @leoneppmd

The column “Spot the evil typo in the most famous guidelines” is back. After endless rounds of revisions, proofreads, and about 200 pairs of eyes scrutinizing every single word, the evil typo still manages to hide in plain sight, buried among a million words — and once you notice

The ESC/EACTS have released new valvular heart disease guidelines at #ESCCongress2025, which lower the age cutoff to recommend TAVI over SAVR and more strongly emphasize patient education, according to ESC chairperson @FabienPraz and EACTS chairperson Michael Borger.

@DomAngellotti @OKhaliqueMD @FabienPraz @joan_bartc @hahn_rt @SpringerNature LINK: https://t.co/cu0DS8dFJY @SusheelKodaliMD @chrisgraeni @AnnaFranzone #PCRTricuspid

#CT #imaging suggests similar #eligibility x #TTVI & comparable TV anatomical phenotypes across severe, massive, and torrential #TR ! A pleasure to co-first author wth @DomAngellotti P. Kampaktsis, led by @OKhaliqueMD & @FabienPraz @joan_bartc @hahn_rt 🙏 @SpringerNature

What’s new in the 2025 guidance on valvular heart disease? 📺 https://t.co/iqpDnVgKJN @Sticchi_Alex interviews 🎤 @FabienPraz and Michael Borger, co-chairs of the 2025 ESC/EACTS Valvular Guidelines Task Force. They discuss the major updates, including the central role of

#JACCIMG state-of-the-art review on #cvImaging in #vhdTR: Advanced imaging has played an essential role in the rapid advancement of Dx & management of tricuspid regurgitation. https://t.co/vVrn67AnUA @sarano_maurice @VDelgadoGarcia @hahn_rt @lpbadano @JoaoLCavalcante @FabienPraz

TRISCEND II subanalysis showed greater benefit of TTVR in massive/torrential TR, suggesting this may be the target population ( https://t.co/OLkOdJCnH4). In our paper just published, massive/torrential TR did not reduce TTVI eligibility vs severe TR ( https://t.co/s8wVRaNOH3)

Main takeaways from new #ESC VHD #guidelines Mitral valve -> Surgery = treatment of choice in PMR -> TEER if high surgical risk in PMR -> Atrial MR → surgery -> Ventricular MR -> TEER -> TMVI may be considered in high-risk severe MR/MS + MAC pts

Are you performing right cath after TTVR? EJHF: First insights into the impact of TR elimination on right heart: Immediate RAP reduction ⬇️ Increased systolic RV/PA pressure⬆️ and PAPi ⬆️ Data From Bern by Fabien Praz 🔗 https://t.co/W0gxh7CxyR @EJHFEiC #CardioTwitter

🆕 New Journal Club! @Jolie_Bruno_ & @AlexMebazaa Mebazaa break down the CONFIDENCE trial (published in the @NEJM): 💊 Finerenone + Empagliflozin in CKD + T2D. 📖Study insights & results here👉 https://t.co/LduiAFpLwZ

[💻REPLAY] - Watch this #PCRWebinar on #tricuspid regurgitation and heart failure with preserved ejection fraction. @MariannaAdamo1 and her team will help you understand the mechanisms & risk factors for heart failure, & much more! ➡️ [ https://t.co/AIgkwLTmC6] #MedEd #cardiology

📊 Real-world data on TTVR unveiled today at #NYValves2025 and simultaneously published in JACC: Cardiovascular Interventions. https://t.co/tWKkgClYhU #CardioResearch

On Day 2 of our postgraduate course on periprocedural echocardiography: Fantastic talks on tricuspid valve intervention tips and tricks delivered by @drmaisano @dralisonduncan @EeLingHeng1 Alexandros Papachristidis, Jim Newton… #zhh @TomLuscher @BSEcho @EchoSoliman

Honored to have participated at the second edition of the postgraduate course on periprocedural #Echofirst organized by @avazir1 @dralisonduncan and @TomLuscher. A superb course with excellent speakers, plenty of expert tips and practical insights, and impressive cases #EACVI

The amazing @denisamuraru lecturing on Right ventricle and Tricuspid valve regurgitation on our Postgraduate course on periprocedural echocardiography. #zhh @TomLuscher @dralisonduncan @EeLingHeng1 @EchoSoliman @zhh_ch @RBHHEducation @EACVIPresident